Cargando…

Osteosarcopenia in autoimmune cholestatic liver diseases: Causes, management, and challenges

Primary biliary cholangitis and primary sclerosing cholangitis (PSC) are the most common cholestatic liver diseases (CLD) in adults and are both characterized by an immune pathogenesis. While primary biliary cholangitis is a model autoimmune disease, with over 90% of patients presenting very specifi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pugliese, Nicola, Arcari, Ivan, Aghemo, Alessio, Lania, Andrea G, Lleo, Ana, Mazziotti, Gherardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048470/ https://www.ncbi.nlm.nih.gov/pubmed/35582674 http://dx.doi.org/10.3748/wjg.v28.i14.1430

Ejemplares similares

Management of patients with autoimmune liver disease during COVID-19 pandemic
por: Lleo, Ana, et al.
Publicado: (2020)

Hepatitis C Virus Infection in the Elderly in the Era of Direct-Acting Antivirals: Evidence from Clinical Trials and Real Life
por: Pugliese, Nicola, et al.
Publicado: (2023)

Fibrosis in Autoimmune and Cholestatic Liver Disease
por: Penz-Österreicher, Melitta, et al.
Publicado: (2011)

Osteosarcopenia School
por: Dionyssiotis, Yannis, et al.
Publicado: (2021)

COVID-19 ed endocrinologia: il caso della tiroide, del diabete e dell’ipovitaminosi D
por: Antonini, Simone, et al.
Publicado: (2021)

Role of liver biopsy in hepatocellular carcinoma
por: Di Tommaso, Luca, et al.
Publicado: (2019)

The benefit of statins in SARS-CoV-2 patients: further metabolic and prospective clinical studies are needed
por: Bifulco, Maurizio, et al.
Publicado: (2020)

Risk stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialists
por: Trivedi, Palak J., et al.
Publicado: (2015)

Relationship between Osteosarcopenia and Frailty in Patients with Chronic Liver Disease
por: Saeki, Chisato, et al.
Publicado: (2020)

Case Report: New CDKN1B Mutation in Multiple Endocrine Neoplasia Type 4 and Brief Literature Review on Clinical Management
por: Lavezzi, Elisabetta, et al.
Publicado: (2022)

Osteosarcopenia: A case of geroscience
por: Kirk, Ben, et al.
Publicado: (2019)

Nivolumab-Induced Autoimmune-Like Cholestatic Hepatitis in a Liver Transplant Recipient
por: Anugwom, Chimaobi, et al.
Publicado: (2020)

Weight change and glycemic control in type 2 diabetes patients during COVID-19 pandemic: the lockdown effect
por: Biamonte, Emilia, et al.
Publicado: (2021)

Time-dependent effect of GLP-1 receptor agonists on cardiovascular benefits: a real-world study
por: Piccini, Sara, et al.
Publicado: (2023)

SARS‐CoV‐2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease
por: Duengelhoef, Paul, et al.
Publicado: (2022)

Osteosarcopenia and Long-COVID: a dangerous combination
por: Tarantino, Umberto, et al.
Publicado: (2022)

Influencing Factors and Molecular Pathogenesis of Sarcopenia and Osteosarcopenia in Chronic Liver Disease
por: Saeki, Chisato, et al.
Publicado: (2021)

Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease
por: Musio, Alessandra, et al.
Publicado: (2023)

Therapeutic approaches to osteosarcopenia: insights for the clinician
por: Fatima, Mizhgan, et al.
Publicado: (2019)

Guidelines for the Management of Cholestatic Liver Diseases (2021)
por: Lu, Lungen
Publicado: (2022)

Evaluation and Management of Chronic Cholestatic Liver Diseases
por: Rini, Sandra Surya, et al.
Publicado: (2023)

Liver tests abnormalities in COVID-19: trick or treat?
por: Vespa, Edoardo, et al.
Publicado: (2020)

The risk of liver cancer in autoimmune liver diseases
por: Lleo, Ana, et al.
Publicado: (2019)

Review of Epidemiology, Diagnosis, and Treatment of Osteosarcopenia in Korea
por: Yoo, Jun-Il, et al.
Publicado: (2018)

Osteosarcopenia: epidemiology, diagnosis, and treatment—facts and numbers
por: Kirk, Ben, et al.
Publicado: (2020)

Osteosarcopenia: A Narrative Review on Clinical Studies
por: Polito, Angela, et al.
Publicado: (2022)

Sarcopenia and osteosarcopenia among patients undergoing hemodialysis
por: Xiang, Ting, et al.
Publicado: (2023)

Common functional alterations identified in blood transcriptome of autoimmune cholestatic liver and inflammatory bowel diseases
por: Ostrowski, Jerzy, et al.
Publicado: (2019)

ACTH Stimulation Test for the Diagnosis of Secondary Adrenal Insufficiency: Light and Shadow
por: Birtolo, Maria Francesca, et al.
Publicado: (2023)

Parathyroid hormone pulsatility: physiological and clinical aspects
por: Chiavistelli, Silvia, et al.
Publicado: (2015)

Liver Transplantation for Patients with Cholestatic Liver Diseases
por: Schöning, Wenzel, et al.
Publicado: (2015)

The Gut-Liver Axis in Cholestatic Liver Diseases
por: Blesl, Andreas, et al.
Publicado: (2021)

Deletion of skeletal muscle Akt1/2 causes osteosarcopenia and reduces lifespan in mice
por: Sasako, Takayoshi, et al.
Publicado: (2022)

Recent developments in the management of idiopathic cholestatic liver disease
por: Imam, Mohamad H., et al.
Publicado: (2012)

Update on pharmacotherapies for cholestatic liver disease
por: Ali, Ahmad H., et al.
Publicado: (2016)

Review: Pathogenesis of cholestatic liver diseases
por: Yokoda, Raquel T, et al.
Publicado: (2020)

The Role of Inflammation in Cholestatic Liver Injury
por: Chen, Jie, et al.
Publicado: (2023)

Gestione clinica della terapia con Denosumab: in chi, quando e come interromperla
por: Pigni, Stella, et al.
Publicado: (2023)

The Genetics of Inherited Cholestatic Disorders in Neonates and Infants: Evolving Challenges
por: Jeyaraj, Rebecca, et al.
Publicado: (2021)

Management and Treatment of Hepatitis C: Are There Still Unsolved Problems and Unique Populations?
por: Solitano, Virginia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7vgc6haqsm6u3feum5sds771sg